Mayo Clinic News Network

News Resources

Items Tagged ‘Minnesota news release’

National DNA Day is April 25; Experts Available for Comment

Posted on April 17th, 2014 by Sam Smith

Digital illustration DNA structure

ROCHESTER, Minn. — Friday, April 25, is National DNA Day, the date which commemorates completion of the Human Genome Project, the national effort to identify and decode all 6 billion letters in human DNA. Since that time, medical researchers and practitioners have found new ways to apply genomics for everyone who needs healing, and thanks to staggering technological advancements and next-generation sequencing, the cost to sequence a patient’s genome has decreased from $3 billion for the first human genome in 2003 to approximately $1,500.

MEDIA: Gianrico Farrugia, M.D., director of the Mayo Clinic Center for Individualized Medicine, is available for interviews and background about the future of genomic medicine, as well as information about the latest practices and transformative clinical trialsTo interview Dr. Farrugia contact Sam Smith, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu

Watch video on genome sequencing:

 

Read the rest of this entry »

Mayo Clinic and Better Team-up to Make Healthcare Experience Simpler

Posted on April 16th, 2014 by Ginger Plumbo

PALO ALTO, Calif. and ROCHESTER, Minn. — April 16, 2014 — Better, a consumer health start-up, and Mayo Clinic have launched a new way for people to navigate the complexity of the healthcare system simply and quickly.  Through a mobile device, Better provides tailored Mayo Clinic health information, 24/7 access to the clinic's experienced and highly-skilled nurses, and a Better Personal Health Assistant who helps simplify and manage people's care so they can use their time to focus on being well.

"Our culture of learning, innovation, and the desire to find answers has allowed Mayo to remain at the forefront of health and wellness, and we want to extend this expertise to people anywhere," explained Paul Limburg, M.D., medical director of Mayo Clinic Global Business Solutions. "People consistently tell us they want more convenient access to Mayo Clinic knowledge. We collaborated with and invested in Better to create a powerful way for people to connect with Mayo Clinic in their homes and communities, wherever they are."
Read the rest of this entry »

Mayo Clinic Launches National Mobile Exhibit Tour to Honor 150 Years, Look to the Future

Posted on April 15th, 2014 by Rebecca Eisenman

ROCHESTER, Minn. — To honor 150 years of serving humanity, Mayo Clinic is taking its story to the public in a free exhibit destined for stops in more than 40 communities throughout the U.S. and Canada from April through October 2014. This high-impact, 1,000-square-foot exhibition on wheels will bring to life Mayo Clinic’s values and our vision for the future of health care

Mayo Clinic Sesquicentennial Mobile Exhibit

“Throughout our history, people have turned to Mayo Clinic for hope and healing. By experiencing this exhibit you will share the enduring values and exciting vision of Mayo Clinic in service to humanity,” says Kerry Olsen, M.D., Chair, Mayo Clinic Sesquicentennial Committee.

What’s inside?
A visit to the exhibit will allow visitors to see the human body as never seen before and discover how we use innovation, research and technology to meet the unique needs of individual patients. Read the rest of this entry »

Expanded Clinical Trial for Experimental Melanoma Drug at Mayo Clinic Cancer Center

Posted on April 15th, 2014 by Joe Dangor

Dr. Roxana DroncaROCHESTER, Minn. — Mayo Clinic Cancer Center announced today that it is participating in an expanded access program for the experimental cancer drug MK-3475 at its three sites in Arizona, Florida and Minnesota. MK-3475 is a therapy for the treatment of metastatic melanoma. This program will provide expanded access to the drug prior to its approval by the Food and Drug Administration (FDA).

MK-3475 received “breakthrough therapy” designation from the FDA based on early interim results from a single-arm, open-label Phase I study in 85 patients with surgically unresectable metastatic melanoma. In that trial, the drug had a 51 percent objective response rate. The objective response includes patients with a complete response, those whose tumors were no longer detectable, and those whose tumors shrunk by at least 30 percent compared to baseline.
Read the rest of this entry »

Are you an Organ Donor? Mayo Clinic Expert Discusses 5 Myths about Organ Donation

Posted on April 15th, 2014 by Ginger Plumbo

April is Donate Life Month; make your wishes known and don’t let misinformation stop you from saving lives

ROCHESTER, Minn. — April is Donate Life Month, a national recognition to help encourage Americans to register as organ, eye and tissue donors and to celebrate those who have saved lives through the gift of donation.

Journalists: Sound bites with Dr. Edwards are in the downloads.

Nationally, Mayo Clinic has over 3,000 patients on the waiting list for an organ transplant. In recognition of Donate Life Month, Brooks Edwards, M.D., director of the William J. von Liebig Center for Transplantation and Donate Life Web BannerClinical Regeneration and a transplant cardiologist, is available to the media to answer common questions and address myths and misconceptions pertaining to organ donation.

Some common myths include:

Myth: If I agree to donate my organs, the hospital staff won't work as hard to save my life.

Fact: When you go to the hospital for treatment, doctors focus on saving your life — not somebody else's. You'll be seen by a doctor whose specialty most closely matches your particular emergency, not by a doctor who performs transplants. Read the rest of this entry »

Mayo Clinic Forms Collaboration with Enterprise Ireland to Develop Novel Technologies

Posted on April 10th, 2014 by Brian Kilen

Collaboration to support medical innovation, improvements in patient care and the economy

Ireland — Mayo Clinic today announced a five-year collaboration with Enterprise Ireland, the Irish enterprise development agency, to advance novel medical technologies originating from Mayo Clinic. The announcement was made this morning in Dublin by An Taoiseach Enda Kenny T.D., the prime minister of Ireland, at the Medical Device 360° conference.

Journalists: B-roll and sound bites with Mayo and Enterprise leaders are available in the downloads.

Leadership from Mayo Clinic and Enterprise Ireland CollaborationThis is a unique collaboration providing an alternative source of funding for translational medical research, especially significant at a time when U.S. funding for research is challenging to obtain. Enterprise Ireland has committed up to $16 million in the agreement.

“This collaboration bridges a financial gap for translational research,” says Greg Gores, M.D. , executive dean for research at Mayo Clinic. “It provides funding in between the early-stage basic research and the stage when a technology is ready for the marketplace. In the U.S., this stage is expensive and difficult to fund. We are providing the technologies and Enterprise Ireland the funding. Both of us are contributing to technology advancement.”

The novel medical technologies are Mayo Clinic innovations that have the potential to make it easier for patients to be diagnosed or treated. The development of one technology is already underway at National University of Ireland, Galway (NUI.G). The inventor, Vijay Singh, M.B.B.S., a gastroenterologist at Mayo Clinic in Arizona, developed a device to treat acute pancreatitis, a disease in which the pancreas is rapidly damaged, causing excruciating pain and often resulting in prolonged hospitalization or sometimes death. Experts at NUI.G are currently preparing the device for human clinical trials, which will be conducted by the university. Read the rest of this entry »

Mayor Ardell Brede to Proclaim April 11 ‘Donate Life Day’ in Rochester

Posted on April 10th, 2014 by Ginger Plumbo

Wear blue and green, attend flag raising ceremony to commemorate

ROCHESTER, Minn. — Rochester Mayor Ardell Brede will proclaim Friday, April 11, “Donate Life Day” in Rochester at a ceremony at the Gift of Life Transplant House (north house) starting at 4 p.m. that day. A 3-by-5-foot Donate Life flag will be raised as part of the ceremony to increase awareness and honor organ donors. The event is open to the public. The Gift of Life Transplant House is located at 705 Second Street SW.

Gift of Life Transplant HouseMore than 120,000 people are waiting for an organ transplant in the United States. Nearly 2,000 of those are children. Mayo Clinic has over 3,000 patients on the waiting list for an organ transplant. Every 10 minutes another name is added to the national waiting list. An average of 18 people die each day in the United States waiting for transplants that can't take place because of the shortage of donated organs.

April is National Donate Life Month, and events are happening across the country to increase support for organ, tissue and eye donation. In addition to the Donate Life Day event in Rochester, there are several other ways to participate or observe Donate Life Month: Read the rest of this entry »

Vigilance for Kidney Problems Key for Rheumatoid Arthritis Patients

Posted on April 9th, 2014 by Sharon Theimer

image of person and kidneysMULTIMEDIA ALERT: Mayo Clinic study finds rheumatoid arthritis patients at higher risk of kidney disease

ROCHESTER, Minn. — Rheumatoid arthritis patients are likelier than the average person to develop chronic kidney disease, and more severe inflammation in the first year of rheumatoid arthritis, corticosteroid use, high blood pressure and obesity are among the risk factors, new Mayo Clinic research shows.  Physicians should test rheumatoid arthritis patients periodically for signs of kidney problems, and patients should work to keep blood pressure under control, avoid a high-salt diet, and eliminate or scale back medications damaging to the kidneys, says senior author Eric Matteson, M.D., Mayo rheumatology chair.  The study is published in the American Journal of Kidney Diseases, the National Kidney Foundation journal .

Researchers studied 813 Mayo Clinic patients with rheumatoid arthritis and 813 without it. They found that over a 20-year period, people with rheumatoid arthritis have a 1 in 4 chance of developing chronic kidney disease, compared with the general population’s 1-in-5 risk.

Journalists: Sound bites with Dr. Matteson are available in the downloads.

Read the rest of this entry »

Mayo Clinic Shares Lessons Learned from Genomics Clinic for Sequencing-based Cancer Care and Diagnostics

Posted on April 8th, 2014 by Sam Smith

ROCHESTER, Minn. — It has been 1.5 years since Mayo Clinic opened the world’s first integrated multidisciplinary genomics service, the Individualized Medicine Clinic, which uses genomics and next-generation sequencing technologies to personalize treatments for patients with advanced cancer and complex diagnoses. In a special issue of the American Journal of Medical Genetics Part C, “Implementation of Genomic Medicine,” developers of the Individualized Medicine Clinic report the clinic’s structure and share lessons learned in everything from efficacy of genomics in patient care to struggles with insurance reimbursement and ethical dilemmas.

A flow cell used in next-generation sequencing. A complete human genome can be decoded from this slide in a few days.

A flow cell used in next-generation sequencing. A complete human genome can be decoded from this slide in a few days.

Konstantinos Lazaridis, M.D., a Mayo Clinic hepatologist and director of the Individualized Medicine Clinic, says the clinic is a natural extension of Mayo’s commitment to putting the needs of the patient first and that leaders in the Mayo Clinic Center for Individualized Medicine saw this opportunity as an imperative. Since opening the clinic, more than 30 percent of patients on a diagnostic odyssey have received answers through whole-exome sequencing.

“We now have the capability to understand cancer and diagnostic odyssey cases at their most fundamental level,” says Dr. Lazaridis. “And while we had many hurdles to overcome in designing and launching this clinic, we continue to improve our services, and that’s what matters to people who need our help.” Read the rest of this entry »

Tissue Testing During Breast Cancer Lumpectomies Prevents Need for Reoperation 96 Percent of Time

Posted on April 7th, 2014 by Sharon Theimer

Real-time tissue analysis gives Mayo Clinic much lower reoperation numbers than national rate

OLYMPUS DIGITAL CAMERAROCHESTER, Minn. — Unique laboratory testing during breast cancer lumpectomies to make sure surgeons remove all cancerous tissue spares patients the need for a repeat lumpectomy in roughly 96 percent of cases at Mayo Clinic in Rochester, a success rate much higher than the rate nationally, a Mayo study shows. During the years reviewed, 13.2 percent of breast cancer lumpectomy patients nationally had to return to the operating room within a month of their initial surgery, compared to 3.6 percent at Mayo in Rochester, which uses a technique called frozen section analysis to test excised tissue for cancer while  patient are still on the operating table. The findings are published in the journal Surgery.

Read the rest of this entry »